This announcement is a separate document:
百诚医药：北京海润天睿律师事务所关于杭州百诚医药科技股份有限公司2023年年度股东大会的法律意见书
Hangzhou Bio-Sincerity Pharma-Tech: Legal Opinion of Beijing Hairun Tianrui Law Firm on the 2023 Annual General Meeting of Shareholders of Hangzhou Baicheng Pharmaceutical Technology Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.